Zacks Research Has Negative View of Henry Schein Q3 Earnings

Henry Schein, Inc. (NASDAQ:HSIC) – Investment analysts at Zacks Research cut their Q3 2025 earnings per share (EPS) estimates for Henry Schein in a research note issued on Thursday, October 17th. Zacks Research analyst R. Department now expects that the company will earn $1.35 per share for the quarter, down from their previous forecast of $1.36. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Zacks Research also issued estimates for Henry Schein’s FY2025 earnings at $5.19 EPS, Q3 2026 earnings at $1.39 EPS and FY2026 earnings at $5.67 EPS.

A number of other analysts have also issued reports on the stock. Evercore ISI increased their price target on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Baird R W raised shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 22nd. Piper Sandler restated an “overweight” rating and set a $86.00 price target on shares of Henry Schein in a report on Friday, June 21st. JPMorgan Chase & Co. cut their price objective on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a report on Monday, August 12th. Finally, Barrington Research restated an “outperform” rating and issued a $82.00 target price on shares of Henry Schein in a research note on Friday, September 20th. One research analyst has rated the stock with a sell rating, six have given a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Henry Schein currently has a consensus rating of “Hold” and an average target price of $77.50.

Henry Schein Stock Down 0.1 %

Shares of Henry Schein stock opened at $71.67 on Friday. The company has a current ratio of 1.55, a quick ratio of 0.90 and a debt-to-equity ratio of 0.46. Henry Schein has a 1 year low of $60.01 and a 1 year high of $82.63. The stock has a 50-day moving average price of $70.26 and a 200 day moving average price of $69.90. The company has a market cap of $9.18 billion, a P/E ratio of 24.21, a P/E/G ratio of 1.98 and a beta of 0.86.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $1.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.01. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The company had revenue of $3.10 billion for the quarter, compared to analysts’ expectations of $3.27 billion. During the same quarter in the previous year, the company posted $1.31 EPS. The business’s revenue was up .0% compared to the same quarter last year.

Institutional Investors Weigh In On Henry Schein

Institutional investors have recently added to or reduced their stakes in the company. Summit Securities Group LLC bought a new stake in shares of Henry Schein in the 2nd quarter worth approximately $31,000. Beach Investment Counsel Inc. PA bought a new position in Henry Schein in the second quarter worth $37,000. Blue Trust Inc. boosted its stake in Henry Schein by 104.2% during the second quarter. Blue Trust Inc. now owns 931 shares of the company’s stock worth $60,000 after buying an additional 475 shares in the last quarter. Mather Group LLC. bought a new stake in Henry Schein in the 1st quarter valued at $97,000. Finally, Livforsakringsbolaget Skandia Omsesidigt increased its holdings in Henry Schein by 282.1% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock valued at $109,000 after buying an additional 1,100 shares during the period. 96.62% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 1.14% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.